ATEC
HealthcareAlphatec Holdings, Inc.
$21.20
+$0.44 (+2.12%)
Jan 5, 2026
Price History (1Y)
Analysis
Alphatec Holdings, Inc. is a healthcare company operating in the medical devices industry. With a market capitalization of $3.15 billion, it is a substantial player within its sector. The company employs approximately 867 individuals and operates within the broader healthcare sector. The company's financial health is marked by significant profitability challenges. Alphatec Holdings reported a gross margin of 69.2%, but this did not translate to positive net income, with the company recording a loss of $154,960,992 over the trailing twelve months. Operating and profit margins were also negative at -4.8% and -21.3%, respectively. Returns on equity and assets were negative as well, standing at -540.4% and -6.0%. The balance sheet shows significant debt with a total of $591.15 million compared to cash reserves of $155.74 million. The company's valuation metrics are notable. Alphatec Holdings has a forward P/E ratio of 103.33 and an EV/EBITDA ratio of 744.15, indicating a premium valuation relative to its peers. The price to book ratio is 271.79. Revenue growth over the year was substantial at 30.4%, but earnings growth figures were not available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Visit website →Key Statistics
- Market Cap
- $3.15B
- P/E Ratio
- N/A
- 52-Week High
- $22.66
- 52-Week Low
- $8.81
- Avg Volume
- 2.32M
- Beta
- 1.02
Company Info
- Industry
- Medical Devices
- Exchange
- NMS
- Country
- United States
- Employees
- 867